Application of hydroxyapatite nanoparticles in development of an enhanced formulation for delivering sustained release of triamcinolone acetonide

We report an analysis of in vitro and in vivo drug release from an in situ formulation consisting of triamcinolone acetonide (TR) and poly(d,l-lactide-co-glycolide) (PLGA) and the additives glycofurol (GL) and hydroxyapatite nanoparticles (HA). We found that these additives enhanced drug release rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Koocheki, Saeid, Madaeni, Sayed Siavash, Niroomandi, Parisa
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090279/
https://www.ncbi.nlm.nih.gov/pubmed/21589650
http://dx.doi.org/10.2147/IJN.S18045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090279/
https://www.ncbi.nlm.nih.gov/pubmed/21589650
http://dx.doi.org/10.2147/IJN.S18045

Ejemplares similares